Effects of Arf6 downregulation on biological characteristics of human prostate cancer cells
AUTOR(ES)
Lei, Haiming; Ma, Fujun; Jia, Renfeng; Tan, Bo
FONTE
Int. braz j urol.
DATA DE PUBLICAÇÃO
2020-12
RESUMO
ABSTRACT Objective To evaluate the effects of Arf6 downregulation on human prostate cancer cells. Materials and Methods The effects of Arf6 downregulation on cell proliferation, migration, invasion and apoptosis were assessed by MTT, BrdU, scratch, Transwell assays and flow cytometry respectively. AKT, p-AKT, ERK1/2, p-ERK1/2 and Rac1 protein expressions were detected by Western blot. Results Downregulating Arf6 by siRNA interference suppressed the mRNA and protein expressions of Arf6. The proliferation capacities of siRNA group at 48h, 72h, and 96h were significantly lower than those of control group (P <0.05). The migration distance of siRNA group at 18h was significantly shorter than that of control group (P <0.01). The number of cells penetrating Transwell chamber membrane significantly decreased in siRNA group compared with that of control group (P <0.01). After 24h, negative control and normal control groups had similar apoptotic rates (P >0.05) which were both significantly lower than that of siRNA group (P <0.01). After Arf6 expression was downregulated, p-ERK1/2 and Rac1 protein expressions were significantly lower than those of control group (P <0.05). Conclusion Downregulating Arf6 expression can inhibit the proliferation, migration and invasion of prostate cancer cells in vitro, which may be related to ERK1/2 phosphorylation and Rac1 downregulation.
Documentos Relacionados
- Requirement for Arf6 in breast cancer invasive activities
- The structural GDP/GTP cycle of human Arf6
- Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells
- Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression.
- Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression.